cobas pulse blood glucose monitoring system— 510(k) K220272
Substantially EquivalentRoche Diagnostics
FDA 510(k) clearance K220272 for cobas pulse blood glucose monitoring system, Substantially Equivalent on 2024-04-26. Applicant: Roche Diagnostics.
Clearance details
- Applicant
- Roche Diagnostics
- Product code
- Code PZI
- Advisory panel
- Clinical Chemistry
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Dual Track
- Location
- Indianapolis, IN, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.